BioCentury | May 24, 2010
Finance

Normalizing oxygen

...Osaka: 4508), following the merger of the Mitsubishi Pharma subsidiary of Mitsubishi Chemical Holdings with Tanabe Seiyaku Co. Ltd....
BioCentury | Feb 16, 2009
Clinical News

Avanafil: Phase III started

...from Mitsubishi Tanabe Pharma Corp. under a 2001 deal. Vivus Inc. (NASDAQ:VVUS), Mountain View, Calif. Tanabe Seiyaku Co. Ltd....
BioCentury | Dec 22, 2008
Clinical News

Avanafil: Phase III started

...from Mitsubishi Tanabe Pharma Corp. under a 2001 deal. Vivus Inc. (NASDAQ:VVUS), Mountain View, Calif. Tanabe Seiyaku Co. Ltd....
BioCentury | Dec 3, 2007
Company News

Genelabs, Mitsubishi Tanabe Pharma deal

...another Phase III trial in April (see BioCentury, April 9). The original deal was with Tanabe Seiyaku Co. Ltd....
BioCentury | Oct 8, 2007
Company News

Mitsubishi Chemical Holdings Corp., Tanabe Seiyaku deal

...Mitsubishi Tanabe Pharma Corp. (see BioCentury, Feb. 12). Mitsubishi Chemical Holdings Corp. (Tokyo:4188), Tokyo, Japan Tanabe Seiyaku Co. Ltd....
BioCentury | Oct 1, 2007
Company News

Ista, Tanabe Seiyaku deal

...Mitsubishi Pharma Corp. (Tokyo, Japan) (see BioCentury, Feb. 12). Ista Pharmaceuticals Inc. (ISTA), Irvine, Calif. Tanabe Seiyaku Co. Ltd....
BioCentury | Aug 13, 2007
Product Development

Speedy delivery

...Speedy delivery Company Product Delivery Status Earliest analgesic effect Cephalon/Tanabe Seiyaku Actiq fentanyl Buccal Mkt Label: Actiq...
BioCentury | Jun 4, 2007
Company News

Medarex, Mitsubishi Pharma deal

...partners will share responsibilities for research. Further terms were not disclosed. Mitsubishi is merging with Tanabe Seiyaku Co. Ltd....
BioCentury | May 14, 2007
Clinical News

Bepotastine: Preliminary Phase II/III data

...last year. Ista Pharmaceuticals Inc. (ISTA), Irvine, Calif. Senju Pharmaceutical Co. Ltd. , Osaka, Japan Tanabe Seiyaku Co. Ltd....
BioCentury | May 9, 2007
Clinical News

Ista reports Phase II/III allergic conjunctivitis data

...redness. Senju (Osaka, Japan) has exclusive worldwide rights to bepotastine, excluding certain Asian countries, from Tanabe Seiyaku...
Items per page:
1 - 10 of 93
BioCentury | May 24, 2010
Finance

Normalizing oxygen

...Osaka: 4508), following the merger of the Mitsubishi Pharma subsidiary of Mitsubishi Chemical Holdings with Tanabe Seiyaku Co. Ltd....
BioCentury | Feb 16, 2009
Clinical News

Avanafil: Phase III started

...from Mitsubishi Tanabe Pharma Corp. under a 2001 deal. Vivus Inc. (NASDAQ:VVUS), Mountain View, Calif. Tanabe Seiyaku Co. Ltd....
BioCentury | Dec 22, 2008
Clinical News

Avanafil: Phase III started

...from Mitsubishi Tanabe Pharma Corp. under a 2001 deal. Vivus Inc. (NASDAQ:VVUS), Mountain View, Calif. Tanabe Seiyaku Co. Ltd....
BioCentury | Dec 3, 2007
Company News

Genelabs, Mitsubishi Tanabe Pharma deal

...another Phase III trial in April (see BioCentury, April 9). The original deal was with Tanabe Seiyaku Co. Ltd....
BioCentury | Oct 8, 2007
Company News

Mitsubishi Chemical Holdings Corp., Tanabe Seiyaku deal

...Mitsubishi Tanabe Pharma Corp. (see BioCentury, Feb. 12). Mitsubishi Chemical Holdings Corp. (Tokyo:4188), Tokyo, Japan Tanabe Seiyaku Co. Ltd....
BioCentury | Oct 1, 2007
Company News

Ista, Tanabe Seiyaku deal

...Mitsubishi Pharma Corp. (Tokyo, Japan) (see BioCentury, Feb. 12). Ista Pharmaceuticals Inc. (ISTA), Irvine, Calif. Tanabe Seiyaku Co. Ltd....
BioCentury | Aug 13, 2007
Product Development

Speedy delivery

...Speedy delivery Company Product Delivery Status Earliest analgesic effect Cephalon/Tanabe Seiyaku Actiq fentanyl Buccal Mkt Label: Actiq...
BioCentury | Jun 4, 2007
Company News

Medarex, Mitsubishi Pharma deal

...partners will share responsibilities for research. Further terms were not disclosed. Mitsubishi is merging with Tanabe Seiyaku Co. Ltd....
BioCentury | May 14, 2007
Clinical News

Bepotastine: Preliminary Phase II/III data

...last year. Ista Pharmaceuticals Inc. (ISTA), Irvine, Calif. Senju Pharmaceutical Co. Ltd. , Osaka, Japan Tanabe Seiyaku Co. Ltd....
BioCentury | May 9, 2007
Clinical News

Ista reports Phase II/III allergic conjunctivitis data

...redness. Senju (Osaka, Japan) has exclusive worldwide rights to bepotastine, excluding certain Asian countries, from Tanabe Seiyaku...
Items per page:
1 - 10 of 93